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Nowadays, in situ gel forming systems are of great importance, having the combi-
ned advantage being patient convenient with favorable residence time for enhancing oc-
ular bioavailability and for reducing systemic side effects (1, 2). The sol-gel transition
can be induced by a shift in the pH (Carbomer) (3), temperature (poloxamer) or by the
presence of deacetylated gellan gum cations (Gelrite) (4).
Poloxamer is a triblock copolymer made of polyethylene oxide (PEO) and polypro-
pylene oxide (PPO) units. Formation of highly ordered structures such as cubic crystal-
line phase and intramolecular hydrogen bonds might promote gelation (6). The muco-
mimetic property of poloxamers is proposed to be due to their hydrophobic and hydro-
philic sequences simulating mucin action by adsorption of the aqueous layer of tears on
the hydrophobic epithelium. This makes them suitable for use as a drug delivery system.
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The purpose of the study was to develop an optimized
thermoreversible in situ gelling ophthalmic drug delivery
system based on Pluronic F 127, containing moxifloxa-
cin hydrochloride as a model drug. A 32 full factorial de-
sign was employed with two polymers: Pluronic F 68
and Gelrite as independent variables used in combination
with Pluronic F 127. Gelation temperature, gel strength,
bioadhesion force, viscosity and in vitro drug release after
1 and 10 h were selected as dependent variables. Pluro-
nic F 68 loading with Pluronic F 127 was found to have a
significant effect on gelation temperature of the formula-
tion and to be of importance for gel formation at tempera-
tures 33–36 °C. Gelrite loading showed a positive effect
on bioadhesion force and gel strength and was also found
helpful in controling the release rate of the drug. The
quadratic mathematical model developed is applicable to
predicting formulations with desired gelation tempera-
ture, gel strength, bioadhesion force and drug release
properties.
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Poloxamer 407 gives a colorless and transparent gel but requires higher concentra-
tion of about 25 to 30 % (m/V) to exhibit sol-gel phase transition at 37 °C when used
alone (7). Gelation temperature can be adjusted within the range of 33–36 °C by modify-
ing cross-linking agents (8), by mixing the different series of poloxamers (9), by chang-
ing the weight of poloxamers (10), or by changing the pH and ionic strength (11). How-
ever, studies have been focused on modulating only gelation temperatures of poloxamer
solutions. There is lack of knowledge of the strength and bioadhesive force of gelled po-
loxamers.
In the present study, an attempt was made to solve this problem by combining two
poloxamers, i.e., Pluronic F 127 (PF 127) and Pluronic F 68 (PF 68), and developing a
series of combinations with gelation temperature ranging from 30 to 36 °C (12). They
were found suitable for formulating an in situ gelling ophthalmic drug delivery system
(IODDS) of moxifloxacin hydrochloride, a fourth-generation fluoroquinolone with en-
hanced activity against Gram-positive bacteria, including S. aureus (5).
PF 127 (15 %, m/V) was selected as the basis of formulation because below this con-
centration it loses its sol-gel transition properties (6). Optimization of PF 68 and Gelrite
used in combination with PF 127 was done using a 32 full factorial design. The effect of
these polymers on gelation temperature, bioadhesion force, gel strength and in vitro re-
lease pattern of the drug was also studied.
EXPERIMENTAL
Materials
Moxifloxacin hydrochloride was obtained from the Torrent Research Centre (India),
PF 127 (high molecular weight) and PF 68 (low molecular weight) were used as received
from BASF India Ltd. (India), Gelrite was obtained from CP Kelco (Singapore). All other
chemicals used were of analytical grade. Simulated tear fluid was freshly prepared and
used 0.0238 mol L–1 NaHCO3, 0.1146 mol L–1 NaCl and 0.0005 mol L–1 CaCl2 ´ 2H2O in
water).
Instruments used were a UV visible spectrophotometer (UV-1800, Shimadzu, Japan),
Brookfield viscometer (model LVT, Brookfield, USA), modified Franz diffusion cell (D.
K. Scientific, India).
Fabrication of in situ gel forming system of moxifloxacin hydrochloride
The gel formulation was prepared aseptically using the cold method (7). The drug
was accurately weighed and dissolved in sterile distilled deionized water and mixed
with mucoadhesive polymer solution, i.e. Gelrite solution previously prepared by heat-
ing at 90 °C and cooled to room temperature (Table I). To this solution, required
amounts of PF 127/PF 68 were added. All other excipients such as benzalkonium chlo-
ride (0.001 %, m/V), sodium chloride 0.5 % (m/V), and disodium-EDTA (0.001 %, m/V),
were added to the mixture. The volume was adjusted with sterile distilled deionized
water to achieve a 0.5 % (m/V) concentration of moxifloxacin hydrochloride. The solu-
tions were adjusted to a pH in the range from 6.8 to 7.4 with 2 mol L–1 NaOH. The solu-
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tions were mixed well and stored at 2–8 °C for 24 h. Formulations were evaluated for
clarity, consistency and spreadability.
Characterization of gel formulations
Gelation temperature. – Gels were evaluated for gelation temperature as described by
Khan et al. (8) and Gilbert et al. (9). Gelation temperature was measured by heating the
formulation in a 15-mL borosilicate glass test tube. Into each test tube, 2 mL of for-
mulation solution was placed and heated with gentle stirring until the formulation solu-
tion got gelled. Gel formation was considered as the point where there was no flow
when the test tubes were tilted more than 90°. All measurements were performed in
triplicate (n = 3).
Content uniformity. – Formulations were tested for content uniformity. Vials (n = 3)
containing the formulation were properly shaken for 2–3 min. One mL of the formula-
tion was transferred into a 100-mL volumetric flask. Fifty mL of simulated tear fluid (pH
7.4) was added. The formed gel was completely crushed with the help of a glass rod, fol-
lowed by vigorous shaking until the formed gel got completely dispersed to give a clear
solution (10). The volume was adjusted to 100 mL with simulated tear fluid. The solu-
tion was filtered through a 0.45-mm filter membrane and the drug concentration was de-
termined with a UV-Visible spectrophotometer at 291 nm.
Bioadhesion force. – Gels were evaluated for bioadhesive force by the method de-
scribed by Choi et al. (11). Excised sheep corneal membrane was immediately fixed with
the mucosal side outwards onto a glass vial using a rubber band. Vials with the corneal
membrane were stored at 37 °C for 5 min. Then, the next vial with a section of mem-
brane was connected to a balance in an inverted position, while the first vial was placed
on a height adjustable pan. The gel was placed onto the corneal membrane of the first
vial. Then, the height of the second vial was adjusted so that the membrane surfaces of
both vials came in close contact. A ten-minute contact time was chosen. The weight was
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Table I. Composition of formulation batches
Formulation
(%, m/V)
M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 M11
MF·HCl 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
PF 127 15 15 15 15 15 15 15 15 15 15 15
PF 68 14 14 14 15 15 15 16 16 16 14.5 15.5
Gelrite 0.3 0.5 0.7 0.3 0.5 0.7 0.3 0.5 0.7 0.6 0.4
BKC 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
Na2-EDTA 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
NaCl 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5
Sterile water q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s.
MF·HCl – moxifloxacin hydrochloride, BKC – benzalkonium chloride
allowed to increase in the pan by adding water until the vials got detached. The bio-
adhesive force was measured as the minimum weight required for detaching two vials.
Gel strength. – Fifty mL of the gel sample was placed in a 100-mL graduated cylinder
and gelled in a thermostat at 37 °C. The apparatus for measuring gel strength, as de-
scribed by Choi et al. (11), was allowed to penetrate into the gel. Gel strength, i.e., the
viscosity of the gel at physiological temperature, was determined by the time (in s)
taken by the apparatus to sink 5 cm through the prepared gel. All measurements were
performed in triplicate (n = 3).
Drug permeation. – A modified device (modified Franz diffusion cell using sheep
cornea as a diffusion membrane) was used for evaluation of drug permeation. This
membrane was tied to a specifically designed glass cylinder (open at both ends). Simu-
lated tear fluid was used as the diffusion medium. The formulation to be tested was
added to the donor chamber with the help of a micropipette. The donor surface of the
membrane was constantly in contact with simulated tear fluid. Temperature of 37 ± 0.5
°C was maintained throughout the study. A magnetic stirrer provided continuous agita-
tion. At regular time intervals, 5 mL of sample was withdrawn and replaced by fresh
simulated tear fluid in order to maintain sink conditions. The samples were analyzed
and absorbance was measured at 291 nm using a UV-VIS spectrophotometer. Cumula-
tive percentage drug release after 1 h (t1) and 10 h (t10) were calculated using the
Beer-Lambert calibration curve in the linearity range of 0–10 mg mL–1.
Drug release data was fitted to different kinetic models like zero-order, first-order,
Higuchi and Korsmeyer-Peppas (12). To find out the mechanism of drug release, 60 %
drug of release data was first fitted in the Korsmeyer-Peppas model equation (13):
Mt/M  ktn (1)
where, Mt/M is fraction of drug released at time t, k is the rate constant and n is the re-
lease exponent. The magnitude of the release exponent n indicates the release mecha-
nism (i.e., Fickian diffusion, case II transport, or anomalous transport). In the present
study, the limits considered were n = 0.45 (indicates classical Fickian diffusion-contro-
lled drug release) and n = 0.89 (indicates a case II relaxational release transport, non-
-Fickian, zero-order release). Values of n between 0.45 and 0.89 can be regarded as an in-
dicator of both phenomena, commonly called anomalous transport or non-Fickian diffusion
(14). Correlation was used as an indicator of the best fitting for each of the models con-
sidered (Table II).
Viscosity. – Viscosity of an instilled formulation is an important factor in determin-
ing the residence time of drug in the eye. The formulations were poured into the sample
adaptor of the Brookfield viscometer and angular velocity was increased gradually from
0.3 to 60 rpm. The hierarchy of angular velocity was reversed and the average dial read-
ing was considered to calculate the viscosity (3). The temperature was maintained
within 37 ± 0.1°C by a recirculating bath connected to the sample cup of the viscometer.
The samples were equilibrated on the plate for 5 min to reach the running temperature
before each measurement.
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Formulation design
A 32 full factorial design was used in the study, in which two factors were evaluated
and experimental trials were performed with all 9 possible combinations. The concentra-
tions of PF68 as X1 (14, 15 and 16 %, m/V) and Gelrite (cation sensitive in situ gelling,
hydrophilic and mucoadhesive polymer) as X2 (0.3, 0.5 and 0.7 %, m/V) were selected as
independent variables. Gelation temperature (GT in °C), gel strength (GS in s), bioad-
hesion force (BF in N), viscosity (h in Pa s) and cumulative percent drug release after 1
and 10 h (t1 and t10, respectively) were selected as dependent variables. The experimen-
tal design is outlined in Table III. DESIGN EXPERT 7.0.11 (STAT-EASE) demo version
software was used for the formulation design. In this design, there are 2 independent
variables and 3 levels (low, medium, and high) of each variable:
Y = b0 + b1X1 + b2X2 + b11X11 + b22X22 + b12X1X2 (1)
where Y is the dependent variable, b0 is the mean response of the 9 runs, and bi is the es-
timated coefficient for factor Xi. The main effects (X1 and X2) represent the average re-
sult of changing a factor at a time from its low to high value. The interaction term (X12)
shows how the response changes when the factors are simultaneously changed. Polyno-
mial terms (X11 and X22) are included to investigate nonlinearity.
Statistical analysis
Statistical analysis of the factorial design batches was performed by multiple regres-
sion analysis using Microsoft Excel®. To evaluate the contribution of each factor with
different levels to the response, the two-way analysis of variance (ANOVA) was perfor-
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Table II. Model fitting of drug release data
Batch code Higuchi Zero First Korsmeyer-Peppas
R2 R2 k (h–n) n
M1 0.9969 0.9922 0.9714 0.9952 0.2393 0.4400
M2 0.9972 0.9885 0.9609 0.9945 0.2189 0.4669
M3 0.9938 0.9968 0.9756 0.9891 0.1828 0.5097
M4 0.9965 0.9920 0.9660 0.9936 0.1971 0.4860
M5 0.9946 0.9975 0.9771 0.9914 0.1968 0.4731
M6 0.9867 0.9988 0.9835 0.9867 0.1535 0.5500
M7 0.9992 0.9859 0.9431 0.9993 0.1978 0.5136
M8 0.9863 0.9981 0.9815 0.9884 0.1683 0.5225
M9 0.9817 0.9977 0.9845 0.9837 0.1282 0.5917
M10a 0.9903 0.9990 0.9851 0.9864 0.1896 0.4396
M11a 0.9985 0.9916 0.9651 0.9957 0.2167 0.4325
a Indicates check point batches.
med. To graphically demonstrate the influence of each factor on the response, the re-
sponse surface plots were generated with the help of design expert software.
RESULTS AND DISCUSSION
Preliminary investigations of the process parameters revealed that factors X1 (%,
m/V, of PF 68) and X2 (%, m/V of Gelrite) highly influenced the rate of in vitro drug re-
lease and hence, they were used for further systematic studies. In the present investiga-
tion, combinations of two polymers were studied using a 32 full factorial design. Mathe-
matical models developed for all the dependent variables using statistical analysis
software are shown in Eqs. (3) – (8):
GT = 33.90778 – 4.58167*X1 – 1.47167*X2 – 0.03167*X12 – 0.02167*X22 – 0.6225*X1*X2
R = 0.9969 (3)
GS = 145.2956 + 7.28*X1 + 7.225*X2 + 3.056667*X12 + 0.221667*X22 + 1.085*X1*X2
R = 0.9985 (4)
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M1 –1 –1 39.67 ± 0.76 135.33 ± 1.53 2255.61 ± 98.07 24.8 66.2 2948
M2 –1 0 38.16 ± 0.76 140.33 ± 1.53 3040.17 ± 98.07 21.5 61.3 3620
M3 –1 +1 37.50 ± 0.50 148.00 ± 2.52 4903.50 ± 98.07 19.6 64.7 3975
M4 0 –1 34.84 ± 0.76 138.33 ± 2.52 2222.92 ± 149.8 23.6 65.4 3910
M5 0 0 34.00 ± 0.50 146.00 ± 2.00 3269.61 ± 56.62 21.6 60.2 4465
M6 0 +1 32.84 ± 3.05 152.00 ± 3.05 5001.57 ± 98.07 18.2 58.7 4896
M7 +1 –1 31.50 ± 0.50 147.33 ± 2.08 2320.99 ± 56.62 20.7 60.3 4157
M8 +1 0 29.50 ± 0.50 155.67 ± 1.15 3432.45 ± 98.07 17.2 57.4 4635
M9 +1 +1 26.84 ± 0.29 164.34 ± 2.52 5132.33 ± 149.8 14.5 52.0 5115
M10a –0.5 +0.5 38.00 ± 0.50 144.67 ± 3.05 4478.53 ± 56.62 20.8 53.9 3200
M11a +0.5 –0.5 35.00 ± 0.50 140.00 ± 3.00 2811.34 ± 56.62 23.2 58.5 4100
Level Low (–1) Medium (0) High (+1)
X1 (%) 14 15 16
X2 (%) 0.3 0.5 0.7
GT – gelation temperature, GS – gel strength, BF – bioadhesion force, t1 – cumulative percent drug release after
1 h, t10 – cumulative percent drug after 10 h, h – viscosity at 37 °C.
a Indicates check point batch.
BF = 3236.649 + 114.415*X1 + 1372.98*X2 + 16.14167*X12 + 392.0767*X22 + 40.8625*X1*X2
R = 0.9990 (5)
t1 = 21.06103 – 2.25634*X1 – 2.79291*X2 – 1.40333*X12 + 0.123824*X22 – 0.24765*X1*X2
R = 0.9954 (6)
t10 = 60.35441 – 3.74223*X1 – 2.75164*X2 – 1.07314*X12 + 1.568433*X22 – 1.71289*X1*X2
R = 0.9652 (7)
h = 4472.4444 + 560.66667*X1 + 495.166667*X2 – 348.666667*X12 – 73.1666667*X22 –
17.25*X1*X2
R = 0.9988 (8)
Lower value of the correlation coefficient, R (Eq. 7) indicated that all formulations
had drug release after 10 h below 70 % (m/V), with insignificant effect of the concentra-
tion of polymers (Table IV). This was due to the formation of a strong polymer gel net-
work and entrapment of the drug inside hydrated polymeric matrices, resulting in sus-
tained release of the drug after 10 h. Gelation temperature, gel strength and bioadhesion
force showed wide variations (Table III). The data clearly indicate that the dependent
variables GT, GS and BF, are strongly dependent on the independent variables. Correla-
tion coefficients indicate a good fit. The polynomial equation can be used to draw a con-
clusion after considering the magnitude of the coefficient and the mathematical sign it
carries (positive or negative).
To demonstrate graphically the effect of the amount of PF68 and Gelrite, response
surface plots were generated for the dependent variables GT, GS, BF and viscosity (Fig. 1).
Results of ANOVA for the measured responses are provided in Table IV. It was
found that the amount of PF68 had a significant effect on gelation temperature of the
system (p < 0.05), while Gelrite had a significant effect on bioadhesion force, gel strength
and t1 (p < 0.05).
As the amount of PF 68 and Gelrite increased, gel strength increased as well; this
must be due to the additional effect of the concentration of both polymers. As Gelrite
concentration increased, the bioadhesion force also increased. However, BF was less af-
fected by the increase of PF 68 concentration than that of Gelrite. This may be due to the
interaction of gellan gum with the mucin of the cul-de-sac. Increased viscosity due to
formation of a denser polymeric network between the long polyoxyethylene-polyoxy-
propylene-polyoxyethylene chains of poloxamers with the gellan gum resulted in in-
creased gel strength of the formulation.
In vitro drug release profiles of the formulations are compared in Fig. 2. To confirm
the diffusion mechanism, the data were fitted into the Korsmeyer-Peppas equation.
Although the type of polymer and its concentration had a significant influence on
gelation temperature, gel strength, bioadhesion force and t1, the diffusion exponent (n)
values showed that diffusion was the predominant mechanism of drug release from these
formulations (R2 of 0.9993), with slope (n) ranging from 0.432 to 0.591 appears to indi-
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Fig. 1. Response surface plot for effects of the amount of PF 68 and Gelrite on: a) gelation tempera-
ture (GT) (°C), b) gel strength (GS) (s), c) bioadhesion force (BF ´ 105, N), d) viscosity (h ´ 10, Pa s),
e) cumulative percentage drug release after 1 h (t1) (%), f) cumulative percentage drug release after
10 h (t10) (%).
X1 – concentration of PF68 (%, m/V)
X2 – concentration of Gelrite (%, m/V)
cate anomalous drug release involving a combination of Fickian and non-Fickian diffu-
sion. This might be due to entrapment of the drug moxifloxacin · HCl into polymer ma-
trices as well as to the difference in characteristics of polymers. Non-linear relationship
was obtained between the diffusion exponent and two independent variables. It was ob-
served that as the concentration of Gelrite increased, the diffusion exponent increased to
an intermediate value and then decreased.
Checkpoint batches M10 and M11 were prepared (Table I) at X1 = –0.5 and 0.5 and
X2 = 0.5 and –0.5 levels, respectively. The actual values of GT (°C), GS (s), BF (kN), vis-
cosity (Pa s) and t1 (%) of batches M10 and M11 are given in (Table V). For the check
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Table IV. Analysis of variance for dependent variables of the 32 full factorial design
Source df SS MS F-value R2 p
Gelation temperature (°C)
Regression 5 140.4978 28.0996 96.17 0.9938 0.0016
Residual 3 0.8766 0.2922
Total 8 141.3744
Gel strength (s)
Regression 5 654.6877 130.9375 193.58 0.9969 0.0006
Residual 3 2.0291 0.6764
Total 8 656.7169
Bioadhesion force ´ 105 (N)
Regression 5 11703637.54 2340727.51 301.60 0.9980 0.0003
Residual 3 23282.88 7760.96
Total 8 11726920.43
Viscosity ´ 10 (Pa s)
Regression 5 81.563 16.313 64.89 0.9976 0.0029
Residual 3 0.754 0.251
Total 8 82.317
t1 (%)
Regression 5 3612256.694 722451.339 251.47 0.9908 0.0004
Residual 3 8618.861 2872.954
Total 8 3620875.556
t10 (%)
Regression 5 148.414 29.683 8.19 0.9317 0.0569
Residual 3 10.879 3.626
Total 8 159.292
SS – sum of squares, df – degree of freedom, MS – mean square, F – Fischer’s ratio, p – significance level,
t1 – cumulative percentage drug release after 1 h, t10 – cumulative percentage drug release after 10 h
point batch M11, the predicted values of 32.49, 145.87, 2.70, 4.40 and 21.1, respectively,
are in good agreement with the actual values of 35, 140, 2.81, 4.10 and 23.2, respectively.
Similarly, the predicted values of batch M10 were also in good agreement with the actual
values.
CONCLUSIONS
When poloxamers were used in combination for developing IODDS, low to moder-
ate amounts of Gelrite and PF 68 were to be used to achieve the desired gelation tempera-
ture, gel strength, mucoadhesion, drug release profile and viscosity required for a sus-
tained ophthalmic drug delivery system of moxifloxacin hydrochloride. It was con-
cluded that the amounts of Gelrite had a significant effect on bioadhesion force and gel
strength of the formulated IODDS. The quadratic mathematical model developed is ap-
plicable to predicting ophthalmic in situ gel formulations with desired characteristics.
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Table V. Comparison of the actual value with predicted values of check point batches
Actual values
Batch code PF68 Gelrite GT (°C) GS (s) BF ´ 105 (N) t1 (%) t10 (%) h ´ 10 (Pa s)
M10 –0.5 +0.5 38 144.67 4478.53 20.79 53.89 3200
M11 +0.5 –0.5 35 140 2811.34 23.18 58.51 4100
Predicted values
Batch code PF68 G GT (°C) GS (s) BF ´ 105 (N) t1 (%) t10 (%) h ´ 10 (Pa s)
M10 –0.5 +0.5 35.60 145.81 3957.77 20.53 61.40 4338
M11 +0.5 –0.5 32.49 145.87 2699.20 21.07 60.41 4404
GT – gelation temperature, GS – gel strength, BF – bioadhesion force, t1 – cumulative percentage of drug













































Fig. 2. Cumulative drug relea-
se of developed formulations.
Mean ± SD, n = 3.
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S A @ E T A K
Termoreverzibilni mukoadhezivni in situ hidrogel za oftalmi~ku primjenu:
Dizajniranje i optimizacija koriste}i kombinaciju polimera
DIVYESH H. SHASTRI, SHAILESH T. PRAJAPATI i LAXMANBHAI D. PATEL
Cilj rada bio je razvoj i optimizacija termoreverzibilnog sustava za isporuku lijeko-
va koji gelira in situ. Sustav je napravljen na bazi Pluronic F 127, a sadr`i moksifloksacin
hidroklorid kao modelni lijek. U radu je primjenjeno 32 potpuno faktorijsko dizajniranje
s dva polimera, Pluronic F 68 i Gelrite kao nezavisnim varijablama koji su kombinirani s
Pluronic F 127. Kao zavisne varijable odabrane su temperatura geliranja, ~vrsto}a gela,
ja~ina bioadhezije, viskoznost i in vitro osloba|anje lijeka nakon 1 i 10 h. Prona|eno je da
Pluronic F 68 u kombinaciji s Pluronic F 127 ima zna~ajan u~inak na temperaturu geli-
ranja u rasponu od 33 do 36 °C. S druge strane, Gelrite ima povoljan u~inak na ja~inu
bioadhezije, ~vrsto}u gela i osloba|anje lijeka. Razvijen je kvadratni matemati~ki model
pomo}u kojeg se mo`e predvidjeti temperatura geliranja, ~vrsto}a gela, ja~ina bioadhe-
zije i osloba|anje ljekovite tvari.
Klju~ne rije~i:moksifloksacin hidroklorid, in situ geliranje, oftalmi~ka isporuka lijeka, mukoadheziv-
ni polimeri, 32 potpuno faktorijsko dizajniranje
Department of Pharmaceutics, K. B. Institute of Pharmaceutical Education and Research, Gandhinagar
382023-Gujarat, India
Department of Pharmaceutics, Shri Sarvajanik Pharmacy College, 384001-Mehsana, India
Director & Professor, C. U. Shah College of Pharmacy and Research, Wadhwan, 363030-Gujarat, India
360
D. H. Shastri et al.: Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of
polymers, Acta Pharm. 60 (2010) 349–360.
